Ozempic Weight Loss Calculator

Estimate your weight loss trajectory on Ozempic, Wegovy, or Mounjaro based on clinical trial curves. Calculate milestone weights and daily protein targets to protect muscle.

Projected Weight Loss

-33 lbs

Projected final weight: 187 lbs

Daily Protein Target

140g / day

Crucial to prevent muscle loss

Daily Hydration Goal

110 oz (3.3L)

Prevents dehydration & GI side-effects

Projected BMI Change

33.5 → 28.4

Based on clinical trial average curve

Your Profile

Projected Milestone Timeline

Month 1 (0.25mg Intro)Week 4 (Avg -2.5%)
215 lbs-6 lbs (BMI 32.6)
Month 3 (0.5mg - 1.0mg)Week 12 (Avg -6.0%)
207 lbs-13 lbs (BMI 31.4)
Month 6 (1.7mg - 2.4mg)Week 24 (Avg -10.5%)
197 lbs-23 lbs (BMI 29.9)
Month 9 (Maintenance)Week 36 (Avg -13.0%)
191 lbs-29 lbs (BMI 29.1)
1 YearWeek 52 (Avg -14.5%)
188 lbs-32 lbs (BMI 28.6)
Full Course (68 Weeks)Week 68 (Avg -15.0%)
187 lbs-33 lbs (BMI 28.4)

Quick Answer: How Much Weight Can You Lose on Ozempic and Wegovy?

In clinical trials, patients taking Semaglutide 2.4 mg (Ozempic / Wegovy) lost an average of 15% of total body weight over 68 weeks (e.g. 33 lbs on a 220 lb person). Patients taking Tirzepatide 15 mg (Mounjaro / Zepbound) achieved an average of 20.9% body weight loss over 72 weeks (e.g. 46 lbs on a 220 lb person).

Semaglutide Standard Dosage Titration Schedule

Titration allows the gastrointestinal system to adjust to delayed gastric emptying, minimizing side effects:

Weeks 1–40.25 mgInitiation Dose
Weeks 5–80.50 mgStep-Up Dose
Weeks 9–121.00 mgIntermediate
Weeks 13–161.70 mgTherapeutic
Week 17+2.40 mgMaintenance

Clinical Trial Benchmark Comparison: STEP-1 vs SURMOUNT-1

Treatment MilestoneSemaglutide 2.4mg (STEP-1)Tirzepatide 15mg (SURMOUNT-1)
Month 1 (Week 4)~2.5% body weight lost~3.5% body weight lost
Month 3 (Week 12)~6.0% body weight lost~8.0% body weight lost
Month 6 (Week 24)~10.5% body weight lost~14.0% body weight lost
Month 9 (Week 36)~13.0% body weight lost~17.5% body weight lost
1 Year (Week 52)~14.5% body weight lost~19.5% body weight lost
Full Course Endpoint14.9% (68 Weeks)20.9% (72 Weeks)

Preserving Lean Muscle on GLP-1 Therapy

When losing weight rapidly, up to one-third of the total loss can consist of metabolically active skeletal muscle rather than adipose tissue. To protect lean mass:

  • Protein Target: Consume 1.2 to 1.6 grams of high-quality protein per kilogram of body weight daily (e.g. 120–160g for an 80kg individual).
  • Resistance Training: Perform compound strength exercises (squats, presses, rows) at least 2 to 3 days per week to signal muscle protein synthesis.
  • Electrolytes & Hydration: Consume water consistently with trace sodium, potassium, and magnesium to prevent fatigue and muscle cramping.

Frequently Asked Questions

What is the expected weight loss timeline on Ozempic / Semaglutide?
Based on the landmark STEP-1 clinical trial published in the New England Journal of Medicine (NEJM), participants taking Semaglutide 2.4 mg lost an average of ~6% of their baseline body weight by week 12, ~12% by week 28, and a cumulative ~15% by week 68. Tirzepatide (Mounjaro/Zepbound) produced ~20.9% average weight loss over 72 weeks in the SURMOUNT-1 trial.
Why is high daily protein intake critical while taking GLP-1 medications?
Because GLP-1 medications significantly suppress appetite, rapid calorie deficits can cause up to 25% to 40% of lost weight to come from lean skeletal muscle rather than fat. Consuming 1.2 to 1.6 grams of protein per kilogram of body weight alongside resistance training is essential to preserve muscle tissue, resting metabolic rate, and physical strength.
How much water should I drink daily on GLP-1s?
GLP-1 medications slow gastric motility and blunt thirst perception. Drinking at least 80 to 100 ounces (2.5 to 3.0 liters) of water daily is vital to prevent dehydration, reduce constipation, and minimize nausea and headaches.
What is the standard dosage titration schedule for Semaglutide?
Standard titration begins at 0.25 mg weekly for 4 weeks (to allow the gastrointestinal tract to adapt), increases to 0.5 mg weekly for 4 weeks, 1.0 mg weekly for 4 weeks, 1.7 mg, and reaches the maximum maintenance dose of 2.0 mg (Ozempic) or 2.4 mg (Wegovy). Always follow your prescribing medical provider's instructions.
What is the difference between Semaglutide (Ozempic) and Tirzepatide (Mounjaro)?
Semaglutide is a single GLP-1 (Glucagon-Like Peptide-1) receptor agonist, while Tirzepatide is a dual GIP (Glucose-Dependent Insulinotropic Polypeptide) and GLP-1 receptor agonist. In clinical trials, Tirzepatide produced approximately 5% to 6% greater average total body weight loss due to synergistic dual-hormone metabolic signaling.
What happens to weight when stopping GLP-1 medications?
In the STEP-1 extension trial, participants who discontinued Semaglutide regained approximately two-thirds of their lost weight within 1 year as appetite signals returned to baseline. Sustaining long-term lifestyle habits (high-protein nutrition, strength training, and sleep) is critical for weight maintenance.
How can you minimize common gastrointestinal side effects?
Eat smaller, more frequent meals, stop eating at the first sensation of fullness, avoid high-fat and fried foods, remain upright for 2 hours after eating, and prioritize fiber and electrolyte hydration.

Related Tools